Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells
US6066317A · kind A · utility
30Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 1998 |
| Grant date | May 23, 2000 |
| Priority date | — |
| Expiry date | Jul 24, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/5431
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel mammalian cytokine, IL-11, and processes for producing it are disclosed. IL-11 may be used in pharmaceutical preparations for stimulating and/or enhancing cells involved in the immune response and cells involved in the proper functioning of the hematopoietic system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.